Lawrence R. Hoffman
Chief Accounting Officer
Tenax Therapeutics, Inc. (TENX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Lawrence R. Hoffman
Lawrence R. Hoffman is recorded as CFO and Chief Accounting Officer at Tenax Therapeutics, Inc. (TENX). Tenax Therapeutics, Inc. reported in an 8-K filed January 12, 2024 that Lawrence R. Hoffman was appointed Interim Chief Financial Officer, effective January 11, 2024.
“On January 9, 2024, the Company's Board of Directors (the "Board") appointed Lawrence R. Hoffman as Interim Chief Financial Officer of the Company effective January 11, 2024 (the "Start Date").”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-01-11–present
-
Current
2024-01-11–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Tenax Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Christopher T. Giordano CEO, Board Member
- Christopher Thomas Giordano CEO, Board Member
- Gerald Proehl Chairman
- Eliot M. Lurier CFO
- Thomas A. McGauley CFO, Chief Accounting Officer
- Thomas R. Staab, II CFO
- Declan Doogan Board Member
- Gerald T. Proehl Board Member
- June Almenoff Board Member
- Keith Maher Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.